GATA3 and carcinoma: The loss of GATA3 expression in PVL-OSCC cases highlighted in the present study may be considered a clinically significant finding, as, if confirmed in larger cohorts, this could establish GATA3 as a negative differentiation marker, with prospective applications in the differential diagnosis of oral epithelial dysplasia and carcinoma.